LEGNANI LAURA

Taglietti, L., Bonapace, G., Clemente, F., Legnani, L., Moricca, M., Mangiatordi, G., et al. (2025). L-Iduronic Acid-Type 1-N-Iminosugars as Pharmacological Chaperones for the Rescue of α-L-Iduronidase in Mucopolysaccharidosis Type I. Intervento presentato a: XIX Convegno-Scuola Sulla Chimica dei Carboidrati (XIX CSCC 2025), Pontignano (SI), Italy. Dettaglio

Celesti, C., Iannazzo, D., Gugliandolo, C., Zammuto, V., Calabrese, L., Trifilò, P., et al. (2025). Bacteria derived bioactive compounds: A valuable tool for the electrochemical detection of arsenic (III) ions in contaminated water. SENSORS AND ACTUATORS REPORTS, 10(December 2025) [10.1016/j.snr.2025.100349]. Dettaglio

Moretti, L., Palmioli, A., Vezzoni, C., Legnani, L., Sperandeo, P., Molteni, L., et al. (2024). Multivalent calix[4]arene-based mannosylated dendrons as new FimH ligands and inhibitors. Intervento presentato a: SCI 2024, Milano, Italia. Dettaglio

Pasquale, A., Chiacchio, M., Acciaretti, F., Della Pergola, R., Legnani, L., Cipolla, L. (2024). The oxidation of d‐galactose into mucic acid (galactaric acid): experimental and computational insights towards a bio‐based platform chemical. ASIAN JOURNAL OF ORGANIC CHEMISTRY, 13(3 (March 2024)) [10.1002/ajoc.202300649]. Dettaglio

Fassi, E., Citarella, A., Albani, M., Milano, E., Legnani, L., Lammi, C., et al. (2024). PCSK9 inhibitors: a patent review 2018-2023. EXPERT OPINION ON THERAPEUTIC PATENTS, 34(4), 245-261 [10.1080/13543776.2024.2340569]. Dettaglio